JUN 06, 2018 05:54 AM PDT

Computer Simulations Offer Alternative Methods for Diabetic Drugs

WRITTEN BY: Nouran Amin

The Governor's Chair for Molecular Biophysics at the University of Tennessee (Knoxville), Jeremy Smith, and the director for the Center for Molecular Biophysics at Oak Ridge National Laboratory, has collaborated with a research team from UT Health Science Center to find a chemical substance that may lower glucose levels in the same efficacy as the common diabetic metformin but with the possibility of being administered in lower dose.

Smith, in collaboration with Jerome Baudry, of the University of Alabama (Huntsville) as well as graduate student Karan Kapoor, from the University of Illinois at Urbana-Champaign, studied high-performance computing to develop sophisticated simulations that suggest chemicals that could activate GPRC6A, which is protein that regulates sugar levels while at the same time corrects abnormalities in pancreatic insulin secretion, glucose uptake into skeletal muscle, and the regulation of glucose and fat metabolism in the liver.

"This chemical compound lowers sugar levels in mice as effectively as metformin, but with a 30-times lower dose," Smith said. "It therefore is a good starting point for the development of a new and effective drug to fight diabetes."

Wolrdwide, about 400 million people suffer from Type 2 diabetes. The global cost of treatment and management of this metabolic disorder is estimated to be a trillion dollars annually. Metformin, a common diabetic drug that works to reduce the liver's production of sugar and lessen the risk of mortality, is currently first-line medication treatment by physicians. However, there remains a dire need for an alternative treatment option for patients who do not respond to metformin as well as others.

 

The computations derived from the research study confirmed that multiple chemical compounds, tested each by the Quarles laboratory at UTHSC, may activate the GPRC6A protein. Furthermore, a team of UTHSC medicinal investigators utilized the results from the research study to synthesize related molecules for pre-clinical testing use. The chemical compound by the name of ‘DJ-V-159’ was identified and concluded to be highly potent in inducing insulin secretion and decreasing glucose levels in mouse models.

 

Source: University of Tennessee at Knoxville

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 09, 2018
Drug Discovery
OCT 09, 2018
Weight Loss Drug Reduces Incidence of Diabetes
A clinical trial weight loss drug, by the name of Lorcaserin—manufactured by Eisai Inc., was found to reduce the risk of diabetes by 19 percent in pa...
NOV 25, 2018
Drug Discovery
NOV 25, 2018
'Longevity protein' Improves Healing in Aging Muscles
A downside to aging is that the skeletal muscles lose their ability to heal after muscle injury. However, a recent research study at the University of Pitt...
DEC 06, 2018
Drug Discovery
DEC 06, 2018
Repurposing Cancer Drugs For HPV Treatment
Drug repurposing is transforming the health care world. The idea that old, previously-- FDA approved drugs could be altered and to be used again for the tr...
DEC 09, 2018
Cannabis Sciences
DEC 09, 2018
Targeting CB1 Endocannabinoid Receptor: Specificity is the Key
The human endocannabinoid system (ECS) is one of the body's largest network of neurotransmitters, receptors, and neuromodulators. This system plays a r...
JAN 12, 2019
Drug Discovery
JAN 12, 2019
The Harms of Prescription Sleeping Pills
In a study published by Frontiers in Behavioral Neuroscience, one of the main class of prescription sleeping pills was found to reduce the ability to wake...
Loading Comments...